10-Q/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q/A

(Amendment No. 1)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2012

[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____ to ____

Commission File Number: 000-54761

ADVANCED VENTURES CORP.

(Exact name of registrant as specified in its charter)

Delaware	42-1772663
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
No. 6 Houjiayu, Wangzuoxiang
Beijing, China	100000
(Address of principal executive offices)	(Zip Code)

+852-53872543

Registrant’s telephone number, including area code

N/A

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes[X] No[ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes[X] No[ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]	Accelerated filer [ ]
Non-accelerated filer [ ] (Do not check if a smaller reporting company)	Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes[X] No[ ]

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date.
82,500,000 shares of common stock as of August 17, 2012.

Explanatory Note

The purpose of this Amendment No. 1 to Advanced Ventures Corp.’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2012, filed with the Securities and Exchange Commission on August 20, 2012 (the “Form 10-Q”), is solely to furnish Exhibit 101 to the Form 10-Q in accordance with Rule 405 of Regulation S-T. Exhibit 101 to this report provides the consolidated financial statements and related notes from the Form 10-Q formatted in XBRL (eXtensible Business Reporting Language).

No other changes have been made to the Form 10-Q. This Amendment No. 1 to the Form 10-Q speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in the original Form 10-Q.

Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities Act of 1934, as amended, and otherwise are not subject to liability under those sections.

ITEM 6. EXHIBITS
Exhibit
Number	Description of Exhibit
31.1*	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act
31.2*	Certification of the Chief Financial Officer Pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act
32.1*	Certification of Chief Executive Officer and Chief Financial officer Under Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema
101.CAL	XBRL Taxonomy Extension Calculation Linkbase
101.DEF	XBRL Taxonomy Extension Definition Linkbase
101.LAB	XBRL Taxonomy Extension Label Linkbase
101.PRE	XBRL Taxonomy Extension Presentation Linkbase

* These exhibits were previously included in Advanced Ventures Corp.’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2012, filed with the Securities and Exchange Commission on August 20, 2012.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ADVANCED VENTURES CORP.
By:	/s/ Christino Rio
	Christino Rio, CEO and Director
	(Principal Executive Officer)
	Date: October 2, 2012
By:	/s/ Benson Lim
	Benson Lim, CFO and Director
	(Principal Financial Officer and
	Principal Accounting Officer)
	Date: October 2, 2012

3

XML

Patent

6 Months Ended

Jun. 30, 2012

Patent [Text Block]

(3) Patent

On July 27, 2010, the Company entered into a Patent Transfer and Sale Agreement whereby the Company acquired all of the right, title and interest in the patent known as the “Catheter with integral anchoring means” for consideration of $17,500. The United States Patent number is 6,743,209. Under the terms of the Patent Transfer and Sale Agreement, the Company was assigned rights to the patent free of any liens, claims, royalties, licenses, security interests or other encumbrances. The cost of obtaining the patent was expensed. The patent was filed on June 1, 2004 and assigned to the Company on July 27, 2010.

XML

Development Stage Activities and Going Concern

6 Months Ended

Jun. 30, 2012

Development Stage Activities and Going Concern [Text Block]

(2) Development Stage Activities and Going Concern

The Company is currently in the development stage, and has no operations. The business plan of the Company is to develop a commercial application of the design in a patent of an “Catheter with integral anchoring means”. The Company also intends to enhance the existing prototype, and manufacture and market the product and/or seek third party entities interested in licensing the rights to manufacture and market the device.

On July 27, 2010, the Company entered into a Patent Transfer and Sale Agreement whereby the Company acquired all of the right, title and interest in the patent known as the “Catheter with integral anchoring means” for consideration of $17,500. The United States Patent number is 6,743,209.

The Company commenced a capital formation activity by filing a Registration Statement on Form S-1 to the SEC to register and sell in a self-directed offering 37,500,000 (post forward stock split) shares of newly issued common stock for proceeds of up to $75,000. The Registration Statement was declared effective on May 10, 2011. On June 16, 2011, the Company issued 37,500,000 (post forward stock split) shares of common stock pursuant to the Registration Statement on Form S-1 for proceeds of $75,000. The offering costs of $20,000 related to this capital formation activity were charged against the capital raised.

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has not established any source of revenue to cover its operating costs, and as such, has incurred an operating loss since inception. Further, as of June 30, 2012, the cash resources of the Company were insufficient to meet its current business plan. These and other factors raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going concern.

XML

BALANCE SHEET (USD $)	Jun. 30, 2012	Dec. 31, 2011
Current Assets:
Cash and cash equivalents	$ 1,211	$ 9,991
Total current assets	1,211	9,991
Total Assets	1,211	9,991
Current Liabilities:
Accounts payable and accrued liabilities	17,515	16,410
Loans from related parties - Directors and stockholders	67,577	28,205
Total current liabilities	85,092	44,615
Total liabilities	85,092	44,615
Commitments and Contingencies	0	0
Stockholders' Equity (Deficit):
Common stock, par value $.0001 per share, 3,000,000,000 shares authorized; 82,500,000 shares issued and outstanding	8,250	8,250
Additional paid-in capital	47,050	47,050
(Deficit) accumulated during the development stage	(139,181)	(89,924)
Total stockholders' Equity (deficit)	(83,881)	(34,624)
Total Liabilities and Stockholders' Equity (Deficit)	$ 1,211	$ 9,991

XML

STATEMENTS OF CASH FLOWS (USD $)	6 Months Ended		24 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012
Operating Activities:
Net (loss)	$ (49,257)	$ (22,873)	$ (139,181)
Changes in net assets and liabilities-
Prepaid expenses	0	0	0
Accounts payable and accrued liabilities	1,105	(4,000)	17,515
Net Cash Used in Operating Activities	(48,152)	(26,873)	(121,666)
Investing Activities:
Net Cash Used in Investing Activities	0	0	0
Financing Activities:
Proceeds from stock issued	0	75,000	75,300
Offering costs paid	0	0	(20,000)
Proceeds from shareholder loans	39,372	29,311	67,577
Net Cash Provided by Financing Activities	39,372	104,311	122,877
Net (Decrease) Increase in Cash	(8,780)	77,438	1,211
Cash - Beginning of Period	9,991	300	0
Cash - End of Period	1,211	77,738	1,211
Cash paid during the period for:
Interest	0	0	0
Income taxes	$ 0	$ 0	$ 0

XML

Schedule of Provision (benefit) for Income Taxes (Details) (USD $)	3 Months Ended		6 Months Ended		24 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012
Federal - Taxable income			$ 0	$ 0
Total current tax provision	0	0	0	0	0
Federal - Loss carryforwards	11,311	5,261	11,311	5,261	11,311
Amortization deduction			134	134
Change in valuation allowance			(11,446)	(5,395)
Total deferred tax provision			$ 0	$ 0

XML

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2012

Summary of Significant Accounting Policies [Text Block]

(1) Summary of Significant Accounting Policies

Basis of Presentation and Organization

Advanced Ventures Corp. (“Advanced Ventures” or the “Company”) is a Delaware corporation in the development stage and has not commenced operations. The Company was incorporated under the laws of the State of Delaware on July 6, 2010. The business plan of the Company is to develop a commercial application of the design in a patent, “Catheter with integral anchoring means”. The Company also intends to enhance the existing prototype, and manufacture and market the product and/or seek third party entities interested in licensing the rights to manufacture and market the device.

Principles of Consolidation

The consolidated financial statements reflect the financial position and operations of the Company and its wholly- owned subsidiary, Advanced Ventures (HK) Ltd. Advanced Ventures (HK) Ltd. was incorporated in Hong Kong on March 27, 2012.

Unaudited Interim Financial Statements

The interim financial statements of the Company as of June 30, 2012, and for the periods then ended, and cumulative from inception, are unaudited. However, in the opinion of management, the interim financial statements include all adjustments, consisting of only normal recurring adjustments, necessary to present fairly the Company’s financial position as of June 30, 2012, and the results of its operations and its cash flows for the periods ended June 30, 2012, and cumulative from inception. These results are not necessarily indicative of the results expected for the calendar year ending December 31, 2012. The accompanying financial statements and notes thereto do not reflect all disclosures required under accounting principles generally accepted in the United States. Refer to the Company’s audited financial statements as of December 31, 2011, filed with the SEC, for additional information, including significant accounting policies.

Cash and Cash Equivalents

For purposes of reporting within the statement of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents.

Revenue Recognition

The Company is in the development stage and has yet to realize revenues from operations. Once the Company has commenced operations, it will recognize revenues when delivery of goods or completion of services has occurred provided there is persuasive evidence of an agreement, acceptance has been approved by its customers, the fee is fixed or determinable based on the completion of stated terms and conditions, and collection of any related receivable is probable.

Loss per Common Share

Basic loss per share is computed by dividing the net loss attributable to the common stockholders by the weighted average number of shares of common stock outstanding during the period. Fully diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. There were no dilutive financial instruments issued or outstanding for the period ended June 30, 2012.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences.

The Company maintains a valuation allowance with respect to deferred tax assets. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carryforward period under the Federal tax laws.

Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the realizability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.

Fair Value of Financial Instruments

The Company estimates the fair value of financial instruments using the available market information and valuation methods. Considerable judgment is required in estimating fair value. Accordingly, the estimates of fair value may not be indicative of the amounts the Company could realize in a current market exchange. The carrying value of accounts payable, accrued liabilities, and loans from directors and stockholders approximated fair value due to the short-term nature and maturity of these instruments.

Deferred Offering Costs

The Company defers as other assets the direct incremental costs of raising capital until such time as the offering is completed. At the time of the completion of the offering, the costs are charged against the capital raised. Should the offering be terminated, deferred offering costs are charged to operations during the period in which the offering is terminated.

Impairment of Long-Lived Assets

The Company evaluates the recoverability of long-lived assets and the related estimated remaining lives when events or circumstances lead management to believe that the carrying value of an asset may not be recoverable. For the period ended June 30, 2012, no events or circumstances occurred for which an evaluation of the recoverability of long-lived assets was required.

Common Stock Registration Expenses

The Company considers incremental costs and expenses related to the registration of equity securities with the SEC, whether by contractual arrangement as of a certain date or by demand, to be unrelated to original issuance transactions. As such, subsequent registration costs and expenses are expensed as incurred.

Estimates

The financial statements are prepared on the basis of accounting principles generally accepted in the United States. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and expenses. Actual results could differ from those estimates made by management.

Fiscal Year End

The Company has adopted a fiscal year end of December 31.

Recent Accounting Pronouncements

In May 2011, the FASB issued ASU 2011-04, "Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and International Financial Reporting Standards ("IFRSs")." Under ASU 2011-04, the guidance amends certain accounting and disclosure requirements related to fair value measurements to ensure that fair value has the same meaning in U.S. GAAP and in IFRS and that their respective fair value measurement and disclosure requirements are the same. ASU 2011-04 is effective for public entities during interim and annual periods beginning after December 15, 2011. Early adoption is not permitted. The Company does not believe that the adoption of ASU 2011-04 will have a material impact on the Company's results of operation and financial condition.

In June 2011, the FASB issued ASU No. 2011-05, "Comprehensive Income (ASC Topic 220): Presentation of Comprehensive Income," ("ASU 2011-05") which amends current comprehensive income guidance. This accounting update eliminates the option to present the components of other comprehensive income as part of the statement of shareholders' equity. Instead, comprehensive income must be reported in either a single continuous statement of comprehensive income which contains two sections, net income and other comprehensive income, or in two separate but consecutive statements. ASU 2011-05 will be effective for public companies during the interim and annual periods beginning after Dec. 15, 2011 with early adoption permitted. The Company does not believe that the adoption of ASU 2011-05 will have a material impact on the Company's results of operation and financial condition.

There were various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries. None of the updates are expected to a have a material impact on the Company's financial position, results of operations or cash flows.

XML

BALANCE SHEET (Parenthetical) (USD $)	Jun. 30, 2012	Dec. 31, 2011
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	82,500,000	82,500,000
Common stock, shares outstanding	82,500,000	82,500,000

XML

Patent (Narrative) (Details) (USD $)	7 Months Ended
	Jul. 27, 2010
Payment to acquire right, title and interest in patent	$ 17,500
United States patent number	6,743,209

XML

Document and Entity Information	6 Months Ended
	Jun. 30, 2012	Aug. 17, 2012
Document and Entity Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2012
Trading Symbol	ancv
Entity Registrant Name	ADVANCED VENTURES CORP
Entity Central Index Key	0001500122
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		82,500,000
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q2

XML

Loans from Related Parties - Directors and Stockholders (Narrative) (Details) (USD $)	Jun. 30, 2012	Dec. 31, 2011
Loans from related parties - Directors and stockholders	$ 67,577	$ 28,205

XML

STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended		24 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012
Revenues	$ 0	$ 0	$ 0	$ 0	$ 0
Expenses:
Professional fees	18,070	18,861	49,603	25,311	122,340
Patent	0	0	0	0	17,500
Legal - incorporation	0	0	0	0	1,500
Franchise Tax	0	0	400	0	400
Miscellaneous expense	77	0	77	0	1,137
Total expenses	18,147	18,861	50,080	25,311	142,877
(Loss) from Operations	(18,147)	(18,861)	(50,080)	(25,311)	(142,877)
Other Income (Expense)	0	0	0	0	0
Foreign currency transaction gains	564	2,438	823	2,438	3,696
Provision for income taxes	0	0	0	0	0
Net (Loss)	$ (17,583)	$ (16,423)	$ (49,257)	$ (22,873)	$ (139,181)
(Loss) Per Common Share:
(Loss) per common share - Basic and Diluted	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted Average Number of Common Shares Outstanding - Basic and Diluted	82,500,000	51,181,320	82,500,000	48,107,730

XML

Income Taxes

6 Months Ended

Jun. 30, 2012

Income Taxes [Text Block]

(6) Income Taxes

The provision (benefit) for income taxes for the period ended June 30, 2012 and 2011 was as follows (assuming a 23% effective tax rate):

		2012			2011
Current Tax Provision:
Federal-
Taxable income	$	-		$	-
Total current tax provision	$	-		$	-
Deferred Tax Provision:
Federal-
Loss carryforwards	$	11,311		$	5,261
Amortization deduction		134			134
Change in valuation allowance		(11,446	)		(5,395	)
Total deferred tax provision	$	-		$	-

The Company had deferred income tax assets as of June 30, 2012 and December 31, 2011, as follows:

		2012			2011
Loss carryforwards	$	28,506		$	17,060
Less - Valuation allowance		(28,506	)		(17,060	)
Total net deferred tax assets	$	-		$	-

The Company provided a valuation allowance equal to the deferred income tax assets for the periods ended June 30, 2012 and December 31, 2011, because it is not presently known whether future taxable income will be sufficient to utilize the loss carryforwards.

As of June 30, 2012, the Company had approximately $124,000 in tax loss carryforwards that can be utilized in future periods to reduce taxable income, and expire by the year 2032.

The Company did not identify any material uncertain tax positions. The Company did not recognize any interest or penalties for unrecognized tax benefits.

The Company will file income tax returns in the United States. All tax years are closed by expiration of the statute of limitations.

XML

Common Stock

6 Months Ended

Jun. 30, 2012

Common Stock [Text Block]

(5) Common Stock

On July 8, 2010, the Company issued 45,000,000 (post forward stock split) shares of its common stock to individuals who are Directors and officers of the company for $300.

The Company commenced a capital formation activity by filing a Registration Statement on Form S-1 to the SEC to register and sell in a self-directed offering 37,500,000 (post forward stock split) shares of newly issued common stock for proceeds of up to $75,000. The Registration Statement was declared effective on May 10, 2011. On June 16, 2011, the Company issued 37,500,000 (post forward stock split) shares of common stock pursuant to the Registration Statement on Form S-1 for proceeds of $75,000. The offering costs of $20,000 related to this capital formation activity were charged against the capital raised.

On February 21, 2012, the Company filed a certificate of amendment of certificate of incorporation to increase the amount of authorized common shares to 3,000,000,000 and to affect a forward stock split of the issued and outstanding common shares on a basis of 15 for 1 all to be effective as of March 7, 2012. The accompanying financial statements and related notes thereto have been adjusted accordingly to reflect this forward stock split.

XML

Schedule of Deferred Income Tax Assets (Details) (USD $)	Jun. 30, 2012	Dec. 31, 2011
Loss carryforwards	$ 28,506	$ 17,060
Less - Valuation allowance	(28,506)	(17,060)
Total net deferred tax assets	$ 0	$ 0

XML

Common Stock (Narrative) (Details) (USD $)	2 Months Ended	6 Months Ended				24 Months Ended
	Mar. 07, 2012	Jun. 30, 2012	Jun. 16, 2011	Jun. 30, 2011	Jul. 08, 2010	Jun. 30, 2012	Feb. 21, 2012	Dec. 31, 2011
Common stock issued for cash			37,500,000		45,000,000
Proceeds from issuance of common stock			$ 75,000		$ 300
Offering costs paid		0	20,000	0		20,000
Common stock, shares authorized		3,000,000,000				3,000,000,000	3,000,000,000	3,000,000,000
Stock split conversion ratio	15
Issuance of 45,000,000 common stock to Directors and officers [Member]
Common stock issued for cash					45,000,000
Proceeds from issuance of common stock					300
Issuance of 37,500,000 common stock for cash [Member]
Common stock issued for cash			37,500,000
Proceeds from issuance of common stock			75,000
Offering costs paid			$ 20,000

XML

Income Taxes (Tables)

6 Months Ended

Jun. 30, 2012

Schedule of Provision (benefit) for Income Taxes [Table Text Block]

		2012			2011
Current Tax Provision:
Federal-
Taxable income	$	-		$	-
Total current tax provision	$	-		$	-
Deferred Tax Provision:
Federal-
Loss carryforwards	$	11,311		$	5,261
Amortization deduction		134			134
Change in valuation allowance		(11,446	)		(5,395	)
Total deferred tax provision	$	-		$	-

Schedule of Deferred Income Tax Assets [Table Text Block]

		2012			2011
Loss carryforwards	$	28,506		$	17,060
Less - Valuation allowance		(28,506	)		(17,060	)
Total net deferred tax assets	$	-		$	-

XML

Related Party Transactions

6 Months Ended

Jun. 30, 2012

Related Party Transactions [Text Block]

(7) Related Party Transactions

As described in Note 4, as of June 30, 2012, the Company owed $67,577 to Directors, officers, and principal stockholders of the Company for working capital loans.

As described in Note 5, on July 8, 2010, the Company issued 45,000,000 (post forward stock split) shares of its common stock to Directors and officers for $300.

XML

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2012

Basis of Presentation and Organization [Policy Text Block]

Basis of Presentation and Organization

Advanced Ventures Corp. (“Advanced Ventures” or the “Company”) is a Delaware corporation in the development stage and has not commenced operations. The Company was incorporated under the laws of the State of Delaware on July 6, 2010. The business plan of the Company is to develop a commercial application of the design in a patent, “Catheter with integral anchoring means”. The Company also intends to enhance the existing prototype, and manufacture and market the product and/or seek third party entities interested in licensing the rights to manufacture and market the device.

Principles of Consolidation [Policy Text Block]

Principles of Consolidation

The consolidated financial statements reflect the financial position and operations of the Company and its wholly- owned subsidiary, Advanced Ventures (HK) Ltd. Advanced Ventures (HK) Ltd. was incorporated in Hong Kong on March 27, 2012.

Unaudited Interim Financial Statements [Policy Text Block]

Unaudited Interim Financial Statements

The interim financial statements of the Company as of June 30, 2012, and for the periods then ended, and cumulative from inception, are unaudited. However, in the opinion of management, the interim financial statements include all adjustments, consisting of only normal recurring adjustments, necessary to present fairly the Company’s financial position as of June 30, 2012, and the results of its operations and its cash flows for the periods ended June 30, 2012, and cumulative from inception. These results are not necessarily indicative of the results expected for the calendar year ending December 31, 2012. The accompanying financial statements and notes thereto do not reflect all disclosures required under accounting principles generally accepted in the United States. Refer to the Company’s audited financial statements as of December 31, 2011, filed with the SEC, for additional information, including significant accounting policies.

Cash and Cash Equivalents [Policy Text Block]

Cash and Cash Equivalents

For purposes of reporting within the statement of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash equivalents.

Revenue Recognition [Policy Text Block]

Revenue Recognition

The Company is in the development stage and has yet to realize revenues from operations. Once the Company has commenced operations, it will recognize revenues when delivery of goods or completion of services has occurred provided there is persuasive evidence of an agreement, acceptance has been approved by its customers, the fee is fixed or determinable based on the completion of stated terms and conditions, and collection of any related receivable is probable.

Loss per Common Share [Policy Text Block]

Loss per Common Share

Basic loss per share is computed by dividing the net loss attributable to the common stockholders by the weighted average number of shares of common stock outstanding during the period. Fully diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. There were no dilutive financial instruments issued or outstanding for the period ended June 30, 2012.

Income Taxes [Policy Text Block]

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are determined based on temporary differences between the bases of certain assets and liabilities for income tax and financial reporting purposes. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences.

The Company maintains a valuation allowance with respect to deferred tax assets. The Company establishes a valuation allowance based upon the potential likelihood of realizing the deferred tax asset and taking into consideration the Company’s financial position and results of operations for the current period. Future realization of the deferred tax benefit depends on the existence of sufficient taxable income within the carryforward period under the Federal tax laws.

Changes in circumstances, such as the Company generating taxable income, could cause a change in judgment about the realizability of the related deferred tax asset. Any change in the valuation allowance will be included in income in the year of the change in estimate.

Fair Value of Financial Instruments [Policy Text Block]

Fair Value of Financial Instruments

The Company estimates the fair value of financial instruments using the available market information and valuation methods. Considerable judgment is required in estimating fair value. Accordingly, the estimates of fair value may not be indicative of the amounts the Company could realize in a current market exchange. The carrying value of accounts payable, accrued liabilities, and loans from directors and stockholders approximated fair value due to the short-term nature and maturity of these instruments.

Deferred Offering Costs [Policy Text Block]

Deferred Offering Costs

The Company defers as other assets the direct incremental costs of raising capital until such time as the offering is completed. At the time of the completion of the offering, the costs are charged against the capital raised. Should the offering be terminated, deferred offering costs are charged to operations during the period in which the offering is terminated.

Impairment of Long-Lived Assets [Policy Text Block]

Impairment of Long-Lived Assets

The Company evaluates the recoverability of long-lived assets and the related estimated remaining lives when events or circumstances lead management to believe that the carrying value of an asset may not be recoverable. For the period ended June 30, 2012, no events or circumstances occurred for which an evaluation of the recoverability of long-lived assets was required.

Common Stock Registration Expenses [Policy Text Block]

Common Stock Registration Expenses

The Company considers incremental costs and expenses related to the registration of equity securities with the SEC, whether by contractual arrangement as of a certain date or by demand, to be unrelated to original issuance transactions. As such, subsequent registration costs and expenses are expensed as incurred.

Estimates [Policy Text Block]

Estimates

The financial statements are prepared on the basis of accounting principles generally accepted in the United States. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and expenses. Actual results could differ from those estimates made by management.

Fiscal Year End [Policy Text Block]

Fiscal Year End

The Company has adopted a fiscal year end of December 31.

Recent Accounting Pronouncements [Policy Text Block]

Recent Accounting Pronouncements

In May 2011, the FASB issued ASU 2011-04, "Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and International Financial Reporting Standards ("IFRSs")." Under ASU 2011-04, the guidance amends certain accounting and disclosure requirements related to fair value measurements to ensure that fair value has the same meaning in U.S. GAAP and in IFRS and that their respective fair value measurement and disclosure requirements are the same. ASU 2011-04 is effective for public entities during interim and annual periods beginning after December 15, 2011. Early adoption is not permitted. The Company does not believe that the adoption of ASU 2011-04 will have a material impact on the Company\'s results of operation and financial condition.

In June 2011, the FASB issued ASU No. 2011-05, "Comprehensive Income (ASC Topic 220): Presentation of Comprehensive Income," ("ASU 2011-05") which amends current comprehensive income guidance. This accounting update eliminates the option to present the components of other comprehensive income as part of the statement of shareholders\' equity. Instead, comprehensive income must be reported in either a single continuous statement of comprehensive income which contains two sections, net income and other comprehensive income, or in two separate but consecutive statements. ASU 2011-05 will be effective for public companies during the interim and annual periods beginning after Dec. 15, 2011 with early adoption permitted. The Company does not believe that the adoption of ASU 2011-05 will have a material impact on the Company\'s results of operation and financial condition.

There were various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries. None of the updates are expected to a have a material impact on the Company\'s financial position, results of operations or cash flows.

XML

Development Stage Activities and Going Concern (Narrative) (Details) (USD $)	6 Months Ended				7 Months Ended	24 Months Ended
	Jun. 30, 2012	Jun. 16, 2011	Jun. 30, 2011	Jul. 08, 2010	Jul. 27, 2010	Jun. 30, 2012
Payment to acquire right, title and interest in patent					$ 17,500
United States patent number					6,743,209
Common stock issued for cash		37,500,000		45,000,000
Proceeds from issuance of common stock		75,000		300
Offering costs paid	$ 0	$ 20,000	$ 0			$ 20,000

XML

Related Party Transactions (Narrative) (Details) (USD $)	6 Months Ended
	Jun. 16, 2011	Jul. 08, 2010	Jun. 30, 2012	Dec. 31, 2011
Common stock issued for cash	37,500,000	45,000,000
Proceeds from issuance of common stock	$ 75,000	$ 300
Loans from related parties - Directors and stockholders			$ 67,577	$ 28,205

XML

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (USD $)	Common Stock [Member]	Additional Paid In Capital [Member]	Development Stage Enterprise Deficit Accumulated During Development Stage [Member]	Total
Beginning Balance at Jul. 06, 2010
Common stock issued for cash (in shares)	45,000,000
Common stock issued for cash	$ 4,500	$ (4,200)		$ 300
Net (loss) for the period			(30,203)	(30,203)
Ending Balance at Dec. 31, 2010	4,500	(4,200)	(30,203)	(29,903)
Ending Balance (in shares) at Dec. 31, 2010	45,000,000
Common stock issued for cash (in shares)	37,500,000
Common stock issued for cash	3,750	51,250		55,000
Net (loss) for the period			(59,721)	(59,721)
Ending Balance at Dec. 31, 2011	8,250	47,050	(89,924)	(34,624)
Ending Balance (in shares) at Dec. 31, 2011	82,500,000
Net (loss) for the period			(49,257)	(49,257)
Ending Balance at Jun. 30, 2012	$ 8,250	$ 47,050	$ (139,181)	$ (83,881)
Ending Balance (in shares) at Jun. 30, 2012	82,500,000

XML

Loans from Related Parties - Directors and Stockholders

6 Months Ended

Jun. 30, 2012

Loans from Related Parties - Directors and Stockholders [Text Block]

(4) Loans from Related Parties - Directors and Stockholders

As of June 30, 2012, loans from related parties amounted to $67,577 and represented working capital advances from Directors who are also stockholders of the Company. The loans are unsecured, non-interest bearing, and due on demand.

XML

Income Taxes (Narrative) (Details) (USD $)	6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Effective tax rate	23.00%	23.00%
Tax loss carryforwards	$ 124,000